VBLT - VBL Therapeutics up 19% premarket on grant for VB-111 April, 21 2020 08:12 AM Vascular Biogenics Ltd. VBL Therapeutics (NASDAQ:VBLT) has been awarded a non-dilutive grant of up to NIS3.175M (~$0.9M) by the Israel Innovation Authority.More news on: Vascular Biogenics Ltd., Healthcare stocks news, Stocks on the move, Read more ...